ÂÜÀòÂÒÂ×

Amol Bhagat has a wealth of experience in formulation development and technology transfer of sterile dosage forms such as injections, lyophilized injections, and ophthalmics for various pharmaceutical companies. With a background in pharmaceutical sciences and quality assurance, Amol has held leadership roles in companies such as Slayback Pharma, DEVA Holding A.Åž., Biocon, Wockhardt, Mylan Laboratories Limited, and Cipla. Amol's expertise includes leading teams, making decisions on regulatory and IP strategies, and collaborating with CROs for custom development.